Jeffrey T. Jochims net worth and biography

Jeffrey Jochims Biography and Net Worth

COO of Owens & Minor

Jeff joined Owens & Minor as Executive Vice President, Strategy & Solutions, in April 2019. He was appointed Executive Vice President & Chief Operating Officer in November 2019. Previously, Jeff served for four years as an executive consultant and board member to firms focused on Life Sciences industries. He also previously served on the board of Sarnova, based in Columbus, Ohio, from 2018- 2019 prior to joining Owens & Minor. Sarnova serves the product needs of the emergency medical services and acute care markets. Since 2017, Jeff has also served on the board of Protochips, a leader in the development and installation of durable goods and consumables for the electron microscopy market. From 2015 to 2018, Jeff was a co-founder and principal of 4C Measures, a technology start-up firm. Before that, Jeff served for 14 years at Thermo Fisher Scientific in positions of increasing authority. He rose to the position of president of Fisher Safety & Fisher Scientific Divisions.

What is Jeffrey T. Jochims' net worth?: The estimated net worth of Jeffrey T. Jochims is at least $1.32 million as of July 1st, 2022. Mr. Jochims owns 195,956 shares of Owens & Minor stock worth more than $1,316,824 as of April 17th. This net worth evaluation does not reflect any other assets that Mr. Jochims may own. Learn More about Jeffrey T. Jochims' net worth.
How do I contact Jeffrey T. Jochims?: The corporate mailing address for Mr. Jochims and other Owens & Minor executives is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. Owens & Minor can also be reached via phone at (804) 723-7000 and via email at truitt.allcott@owens-minor.com. Learn More on Jeffrey T. Jochims' contact information.
Has Jeffrey T. Jochims been buying or selling shares of Owens & Minor?: Jeffrey T. Jochims has not been actively trading shares of Owens & Minor during the last ninety days. Learn More on Jeffrey T. Jochims' trading history.
Who are Owens & Minor's active insiders?: Owens & Minor's insider roster includes Robert Henkel (Director), Jeffrey Jochims (COO), Jonathan Leon (SVP), Andrew Long (CFO), Michael Lowry (SVP), Shana Neal (Insider), Nicholas Pace (EVP), and Edward Pesicka (CEO). Learn More on Owens & Minor's active insiders.
Are insiders buying or selling shares of Owens & Minor?: During the last year, Owens & Minor insiders bought shares 5 times. They purchased a total of 2,718,412 shares worth more than $24,495,308.48. During the last year, insiders at the sold shares 6 times. They sold a total of 42,205 shares worth more than $749,344.10. The most recent insider tranaction occured on April, 9th when Major Shareholder Coliseum Capital Management, L bought 225,000 shares worth more than $1,662,750.00. Insiders at Owens & Minor own 3.6% of the company. Learn More about insider trades at Owens & Minor.
Information on this page was last updated on 4/9/2025.

Jeffrey T. Jochims Insider Trading History at Owens & Minor

Jeffrey T. Jochims Buying and Selling Activity at Owens & Minor

Owens & Minor Company Overview

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

Today's Range

Now: $6.72

$6.60

$6.97

50 Day Range

MA: $8.32

$6.23

$10.12

2 Week Range

Now: $6.72

$6.07

$25.82

Volume

1,812,824 shs

Average Volume

1,089,641 shs

Market Capitalization

$519.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02